Disease: Oral candidiasis

Antifungal Efficacy of Ganoderma lucidum and Clotrimazole for Treatment of Denture Stomatitis: A Randomized Clinical Trial

This study tested whether Ganoderma lucidum, a medicinal mushroom used in traditional Asian medicine, could treat denture stomatitis as effectively as the standard treatment clotrimazole. Both treatments reduced pain and improved symptoms equally well over two weeks. The results suggest that Ganoderma lucidum could be a useful alternative for patients who don’t respond well to standard antifungal drugs.

Read More »

Clinical Isolate of Candida tropicalis from a Patient in North Carolina: Identification, Whole-Genome Sequence Analysis, and Anticandidal Activity of Ganoderma lucidum

Researchers in North Carolina identified a drug-resistant yeast infection (Candida tropicalis) from a hospital patient and tested whether extracts from reishi mushrooms (Ganoderma lucidum) could kill it. Using genetic analysis, they found mutations in the yeast that help it resist antifungal drugs. All three types of mushroom extracts tested successfully stopped the yeast’s growth and damaged its cells, suggesting that reishi mushrooms could be a promising natural treatment option for hard-to-treat candida infections.

Read More »

Addressing Critical Fungal Pathogens Under a One Health Perspective: Key Insights from the Portuguese Association of Medical Mycology

Four dangerous fungal species pose growing threats to human health worldwide, especially for people with weakened immune systems. Portugal’s medical experts have reviewed the current situation, finding these fungi increasingly resistant to treatment, present in hospitals and the environment, and occasionally spreading from animals to people. The review emphasizes the need for better testing, coordinated tracking systems, and approaches that consider human, animal, and environmental health together to combat this emerging crisis.

Read More »

Antifungal Effects of Pterostilbene on Candida albicans, Candida dubliniensis, and Microcosm Biofilms of Denture Stomatitis

Pterostilbene, a natural compound found in blueberries and grapes, has been shown to effectively kill Candida fungi that cause denture-related mouth infections. In laboratory tests, it successfully eliminated fungal cells and disrupted harmful biofilms within 8 hours. When tested in a living organism model, pterostilbene proved safe and reduced infection severity, suggesting it could be a promising natural alternative to conventional antifungal medications.

Read More »

Evaluation of Antifungal Activity Against Candida albicans Isolates From HIV-Positive Patients with Oral Candidiasis in a Major Referral Hospital, West Java, Indonesia

This study examined fungal infections in HIV-positive patients suffering from oral candidiasis (mouth thrush) in Indonesia. Researchers identified the types of Candida fungi present and tested their resistance to four common antifungal medications. Most patients had Candida albicans, and while these fungi generally responded well to newer antifungal drugs like voriconazole and fluconazole, some showed resistance, particularly to fluconazole, suggesting the need for careful testing before prescribing treatment.

Read More »

Evaluation of antifungal effect of amphotericin B in comparison with nystatin on Candida species derived from patients undergoing head-and-neck radiotherapy

This study compared two antifungal medications (nystatin and amphotericin B) for treating oral yeast infections in cancer patients receiving head-and-neck radiotherapy. Researchers tested how well each drug worked against different Candida yeast species before and during radiation treatment. The results showed that nystatin was more effective than amphotericin B at killing the yeasts, with nystatin working against all yeast species tested, while amphotericin B had reduced effectiveness against some Candida albicans strains.

Read More »

Functional Amyloids in Adhesion of Non-albicans Candida Species

Candida fungi cause common infections and form tough biofilms that resist treatment. These fungi stick to body surfaces using proteins called adhesins that form amyloid-like structures. Researchers found that special peptides can block these amyloid structures in several Candida species, preventing them from sticking to cells and potentially offering a new way to fight these infections.

Read More »

Evaluation of Antifungal Activity Against Candida albicans Isolates From HIV-Positive Patients with Oral Candidiasis in a Major Referral Hospital, West Java, Indonesia

This study examined fungal infections of the mouth in HIV-positive patients in Indonesia. Researchers identified different types of Candida fungi and tested how well common antifungal medications worked against them. While most medications were effective, they found some cases of drug resistance, suggesting the importance of proper testing to choose the best treatment for each patient.

Read More »

Antifungal efficacy of caffeic acid and nano-caffeic acid particles against candidiasis: an in vitro study

Researchers developed a nano-particle form of caffeic acid, a natural compound found in coffee and tea, to treat oral yeast infections (candidiasis). The nano-version showed better antifungal activity than regular caffeic acid, though not as strong as prescription antifungal drugs. Since it comes from plants with fewer side effects, it could offer an alternative treatment option for patients with candidiasis.

Read More »

Candida albicans Goliath cells pioneer biofilm formation

Researchers discovered that Candida albicans produces giant-sized cells called Goliath cells when zinc is scarce. These oversized cells are extremely sticky and can cling to plastic surfaces like catheters even when exposed to blood flow. Once attached, they form thicker, more resilient biofilms that can seed infections into the bloodstream, making Goliath cells particularly dangerous in hospital settings where catheters are commonly used.

Read More »
Scroll to Top